SuperworthButterfly Network price to sales ratio BFLY
Market value divided by revenue over the last twelve months, since 2022.
- Today, Oct 23, 2026
- 16.1×
- 5-year median
- 6.7×
- Against its 5-year history
- 89th
- percentile: 0 is its lowest day, 100 its highest
- 5-year range
- 2.2× to 25.2×
- Peer median
- 3.0×
Butterfly Network's price to sales ratio is 16.1× as of Oct 23, 2026.
That is above its 5-year median of 6.7×, higher than on 89% of days in the last 5 years.
Over that time it ranged from 2.2× in Oct 2023 to 25.2× in Aug 2022.
The median for 5 medical device stocks of a similar size is 3.0×.
Price to sales ratio over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 16.1× | 8.5× | 22.7× |
| 2025 | 11.0× | 3.8× | 13.3× |
| 2024 | 9.7× | 2.4× | 9.7× |
| 2023 | 3.3× | 2.2× | 8.1× |
| 2022 | 6.7× | 6.4× | 25.2× |
Against its peers
Companies in Medical - Devices nearest Butterfly Network's size, closest first, today.
| Company | Price to sales ratio |
|---|---|
| BFLYButterfly Network | 16.1× |
| CNMDCONMED | 1.1× |
| TMDXTransMedics | 3.7× |
| ITGRInteger | 2.3× |
| LIVNLivaNova | 3.0× |
| ELMDElectromed | 3.0× |
| Peer median | 3.0× |
Where Butterfly Network ranks
What the price to sales ratio tells you
Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.
Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.
More on Butterfly Network
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.